Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Novonix ADR | NVX | Oct 11, 2024 | 2.30 | -4.17 |
NRG Energy | NRG | Oct 11, 2024 | 89.75 | +2.45 |
NRx Pharmaceuticals | NRXP | Oct 11, 2024 | 1.37 | -0.36 |
NSTS Bancorp | NSTS | Oct 11, 2024 | 10.83 | +2.17 |
Nu Holdings | NU | Oct 11, 2024 | 13.71 | +2.08 |
Nu Skin Enterprises | NUS | Oct 11, 2024 | 6.27 | +0.16 |
Nuburu | BURU | Oct 11, 2024 | 1.04 | +0.97 |
NuCana ADR | NCNA | Oct 11, 2024 | 2.14 | -0.93 |
Nucor | NUE | Oct 11, 2024 | 151.91 | +0.67 |
Nukkleus | NUKK | Oct 11, 2024 | 0.27 | -0.83 |
Nurix Therapeutics | NRIX | Oct 11, 2024 | 23.63 | +8.10 |
NuScale Power | SMR | Oct 11, 2024 | 13.14 | +9.50 |
Nustar Energy C Pref | NS-C | Oct 11, 2024 | 24.99 | 0.00 |
Nutanix A | NTNX | Oct 11, 2024 | 64.61 | 0.00 |
Nutex Health | NUTX | Oct 11, 2024 | 19.79 | +4.60 |
Nutriband | NTRB | Oct 11, 2024 | 7.91 | +11.41 |
Nutrien | NTR | Oct 11, 2024 | 49.05 | +0.04 |
Nuvalent A | NUVL | Oct 11, 2024 | 103.59 | +1.13 |
Nuvation Bio A | NUVB | Oct 11, 2024 | 2.27 | +12.94 |
Nuvectis Pharma | NVCT | Oct 11, 2024 | 6.40 | +3.39 |
Nuveen Amtfree Municipal Credit Income Fund | NVG | Oct 11, 2024 | 13.38 | +0.22 |
Nuveen Amtfree Municipal Value Fund | NUW | Oct 11, 2024 | 14.29 | +0.21 |
Nuveen Amtfree Quality Municipal Income Fund | NEA | Oct 11, 2024 | 11.92 | +0.34 |
Nuveen Arizona Quality Municipal Fund | NAZ | Oct 11, 2024 | 11.83 | +0.08 |
Nuveen California Amtfree Quality Municipal Income Fund | NKX | Oct 11, 2024 | 13.54 | +0.45 |
Nuveen California Municipal Value Fund | NCA | Oct 11, 2024 | 9.15 | +0.44 |
Nuveen California Quality Municipal Income Fund | NAC | Oct 11, 2024 | 11.85 | 0.00 |
Nuveen California Select Taxfree Income Portfolio | NXC | Oct 11, 2024 | 13.91 | -0.32 |
Nuveen Churchill Direct Lending | NCDL | Oct 11, 2024 | 17.53 | -0.40 |
Nuveen Core Equity Alpha Fund | JCE | Oct 11, 2024 | 15.34 | +0.26 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.